Back

Eris Lifesciences Ltd.

IPO Details · GMP · Subscription · Financials

✅ Listed NSE & BSE Mainboard Live Chart
Issue Price
₹603
Per Share
GMP
NIL
Grey Market
Est. Listing
₹603
Expected Price
Min. Application
₹28,944
2 lots × 24 shares
IPO Issue Details
Issue Price / Price Band₹603 per share (Fixed Price)
Face Value₹1 Per Share
Lot Size24 Shares per Lot
Total Issue Size2,88,75,000 shares (aggregating up to ₹1,740.49 Cr)
Issue TypeBookbuilding IPO
Sale Type / CategoryOffer For Sale
Exchange / PlatformNSE & BSE
IPO TypeMainboard
Subscription OpenFri, 16 Jun 2017
Subscription CloseTue, 20 Jun 2017
Anchor AllotmentThu, 15 Jun 2017
Basis of AllotmentFri, 23 Jun 2017
Initiation of RefundsTue, 27 Jun 2017
Credit of Shares to DematWed, 28 Jun 2017
Listing DateThu, 29 Jun 2017
UPI Mandate Deadline2017-06-20
Application & Investment Details
Retail — Min (1 Lots)₹14,472 — 24 shares
Retail — Max (13 Lots)₹188,136 (13 Lots)
HNI — Min (14 Lots)₹2,02,608 — 336 shares
Pre-IPO Promoter Holding13,75,00,000 shares
Post-IPO Promoter Holding13,75,00,000 shares
About Eris Lifesciences Ltd.

Incorporated in 2007, Eris Lifescience Ltd is Ahmedabad, Gujrat based pharmaceutical company engaged in research, development, manufacturing and selling of select therapeutic areas within the chronic and acute categories of the Indian Pharmaceutical Market.Eris product portfolio is primarily focused on therapeutic areas which require the intervention of super specialist and specialist doctors such as Diabetologists, Endocrinologists Cardiologists, and Gastroenterologists.Eris products in the chronic category cater primarily to the therapeutic areas including cardiovascular, anti-diabetics and neurology, chronic respiratory and chronic pain (analgesics).In acute category, the product portfolio includes vitamins, gastroenterology, anti-infectives, gynaecology, cute respiratory, acute pain (analgesics), hepatoprotectives, hormones, hematology, dermatology, anti-obesity products and products for injury healing.Eris Lifescience own and operate a manufacturing facility in Guwahati, Assam. They also outsource the manufacturing of certain of its products to 20 manufacturers. Eris strong sales team comprised of 1,310 marketing representatives.Eris Lifescience Strengths:• Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders• Portfolio of high volume and leading brands• Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and concentration of specialists and super specialists• Multi-faceted product selection and engagement model leading to growth in prescription• Strong sales, marketing and distribution capabilities

Objects of the Issue

Eris Lifesciences Ltd. proposes to utilise the net proceeds from the Issue for the following objects:

1
1 The company will not receive any proceeds from the Offer and all the proceeds will go to the Selling Shareholders.
Shareholding & Lock-in
Pre-IPO Promoter Holding 13,75,00,000 shares
Post-IPO Promoter Holding 13,75,00,000 shares
Lock-in Period (30%)July 23, 2017
Lock-in Period (50%)September 21, 2017
Check AllotmentCheck Status →
Eris Lifesciences Ltd. — Live Price LIVE
₹603.00
INR · BSE
Fetching live data…
VS Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading chart…
Chart Not Available
Eris Lifesciences Ltd. is not yet listed on Yahoo Finance or has a different ticker symbol.
Try again after listing stabilises (2-3 trading days).
Issue ₹603.00 Live Price
Quick Facts
GMP Signal ⚪ No GMP
StatusListed
Issue Price₹603
GMPNIL
Est. Listing₹603
Lot Size24 shares
Min Amount₹28,944
Listing Date29 Jun 2017
Disclaimer: GMP is unofficial and unregulated. It does not guarantee actual listing price.
Listing Performance
Issue Price₹603
Listing Date29 Jun 2017
Listing Price
Listing Gain/Loss—%
52-Week High
52-Week Low
Issue Structure & Reservation
Category Shares Offered % Issue Amount (₹ Cr)* Subscription
TOTAL 28,875,000 100.00% ₹1,741.16 Cr
* Based on ₹603.00 (upper price band)
Lot Size & Investment Details
Lot Size
24
Shares
Issue Price
₹603.00
Per Share
Min Investment
₹14,472
1 Lot
Category Lots Shares Amount (₹)
Retail (Min) 1 24 ₹14,472
Retail (Max) 13 312 ₹188,136
sNII (Min) 14 336 ₹202,608
bNII (Min) 70 1,680 ₹1,013,040
Company Financials — Restated Consolidated (Amount In Crore)
Particulars31-Mar-1631-Mar-1531-Mar-14
Revenue from Operations 597.02 545.56 508.82
EBITDA N/A N/A N/A
Profit After Tax (PAT) 134.86 89.26 70.91
Net Worth N/A N/A N/A
Total Assets 397.36 357.29 270.60
Reserves & Surplus N/A N/A N/A
Total Borrowings N/A N/A N/A
Key Ratios & Valuation
Issue Price ₹603
Face Value ₹1 Per Share
P/BV N/A
RoE N/A
RoCE N/A
RoNW N/A
PAT Margin (%) N/A
EBITDA Margin (%) N/A
Debt / Equity N/A
Company Details
Company
Eris Lifesciences Ltd.
Exchange
NSE & BSE
IPO Type
Mainboard IPO
Issue Type
Bookbuilding IPO
Face Value
₹1 Per Share
Script Code
N/A
Address
7th Floor, Commerce House IV, Beside Shell Petrol Pump, 100 Feet Road, Prahladnagar, Ahmedabad 380 015 Ahmedabad, Gujarat
Book Running Lead Managers
Axis Capital Ltd.
Book Running Lead Manager (BRLM)
Citigroup Global Markets India Pvt.Ltd.
Book Running Lead Manager (BRLM)
Credit Suisse Securities (India) Pvt.Ltd.
Book Running Lead Manager (BRLM)